Compare VCEL & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | NEOG |
|---|---|---|
| Founded | 1989 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1996 | 1995 |
| Metric | VCEL | NEOG |
|---|---|---|
| Price | $46.23 | $9.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $57.75 | $10.67 |
| AVG Volume (30 Days) | 598.5K | ★ 1.9M |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $276,259,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | ★ N/A | $475.50 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $4.56 |
| 52 Week High | $43.57 | $11.43 |
| Indicator | VCEL | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 81.81 | 56.10 |
| Support Level | $32.47 | $8.86 |
| Resistance Level | N/A | $9.50 |
| Average True Range (ATR) | 1.61 | 0.34 |
| MACD | 0.70 | 0.04 |
| Stochastic Oscillator | 96.76 | 76.22 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.